Preview Mode Links will not work in preview mode

AJP Residents' Journal


Oct 27, 2019

In this episode, Cameron Kiani interviews Ken Gillman, MD, on using Monoamine Oxidase Inhibitors in clinical practice.
 
Dr. Gillman is a Queensland-based psychiatrist considered to be one of the world's leading experts on MAOIs. He recently published a statement “Revitalizing monoamine oxidase inhibitors: a call for action” in the journal CNS Spectrums. 
 
Cameron Kiani is a fourth year medical student at Icahn School of Medicine at Mount Sinai with an interest in treatment-resistant mood disorders. 
 
“Revitalizing monoamine oxidase inhibitors: a call for action”
 
https://www.cambridge.org/core/journals/cns-spectrums/article/revitalizing-monoamine-oxidase-inhibitors-a-call-for-action/32497C0FE4F08D0D4C07E6350A91B0EE